| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |